Supplementation with Matured Hop Bitter Acids Improves Cognitive Performance and Mood State in Healthy Older Adults with Subjective Cognitive DeclineJOURNAL OF ALZHEIMERS DISEASEIF3.12020-06-3013OAAI
Young age and severity of motor function are risk factors for psychosis after subthalamic nucleus deep brain stimulation for Parkinson's diseasePSYCHIATRY AND CLINICAL NEUROSCIENCESIF6.22020-02-270OAAI
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic EffectSCHIZOPHRENIA BULLETINIF4.82018-10-03102OAAI
Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in SchizophreniaFRONTIERS IN PSYCHIATRYIF3.22018-03-1321OAAI
High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophreniaPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92017-06-0113OAAI
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophreniaPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92017-06-018OAAI
Estimated cognitive decline in patients with schizophrenia: A multicenter studyPSYCHIATRY AND CLINICAL NEUROSCIENCESIF6.22016-12-1553OAAI
Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case-control studyINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82016-10-045OAAI
Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders (vol 7, pg 10594, 2016)NATURE COMMUNICATIONSIF15.72016-04-200OAAI
Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disordersNATURE COMMUNICATIONSIF15.72016-02-0342OAAI
Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive ImpairmentPLOS ONEIF2.62016-01-0727OAAI
Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot studyCLINICAL INTERVENTIONS IN AGINGIF3.72016-01-0166OAAI
Genetic Association Between KIBRA Polymorphism and Alzheimer's Disease with in a Japanese Population (vol 17, pg 170, 2015)NEUROMOLECULAR MEDICINEIF3.92015-04-210OAAI
Genetic Association Between KIBRA Polymorphism and Alzheimer's Disease with in a Japanese PopulationNEUROMOLECULAR MEDICINEIF3.92015-03-249PREAI
Association between the catechol-O-methyltransferase polymorphism Val158Met and Alzheimer's disease in a Japanese populationINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82014-12-096OAAI
Significance of Measurements of Peripheral Carbonyl Stress Markers in a Cross-sectional and Longitudinal Study in Patients With Acute-stage SchizophreniaSCHIZOPHRENIA BULLETINIF4.82014-01-2132OAAI
The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophreniaPSYCHIATRY RESEARCHIF3.92013-12-017PREAI
Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer's diseaseJOURNAL OF NEURAL TRANSMISSIONIF42013-11-0822PREAI
Genetic association between APOA1 and APOD polymorphisms and Alzheimer's disease in a Japanese populationJOURNAL OF NEURAL TRANSMISSIONIF42013-05-2114PREAI
NO CORRELATION BETWEEN PLASMA NMDA-RELATED GLUTAMATERGIC AMINO ACID LEVELS AND COGNITIVE FUNCTION IN MEDICATED PATIENTS WITH SCHIZOPHRENIAINTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINEIF1.32012-11-0610PREAI